Cangrelor
ATC Code
B01AC25
Cangrelor
Definition
An inhibitor of the platelet adenosine diphosphate (ADP) P2Y12 receptor (P2Y12R), with antiplatelet activity. Upon administration, cangrelor selectively and reversibly binds to P2Y12R, and blocks the platelet signaling pathway. This inhibits the activation of the glycoprotein complex GPIIb/IIIa, fibrinogen binding to platelets and platelet adhesion and aggregation.
Also known as AR-C69931MX, CANGRELOR — per NCIT
Also identified as
- ATC B01AC25 per RXNORM
- NCIT NCIT:C76395 per NCIT
- SCTID 716118009 per RXNORM
- SCTID 763606005 per RXNORM
- UNII 6AQ1Y404U7 per RXNORM
Indications
| Disease | Relation | Source |
|---|---|---|
| Coronary thrombosis | may prevent | MEDRT · Public domain (U.S. Government work) |
| Myocardial infarction | may prevent | MEDRT · Public domain (U.S. Government work) |
| Stroke | may prevent | MEDRT · Public domain (U.S. Government work) |